Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

1350. Characterization of the Type of Specimen Used for Testing of Sexually Transmitted Infections in Outpatient Clinics

1350. Characterization of the Type of Specimen Used for Testing of Sexually Transmitted... 1350. Characterization of the Type of Specimen Used for Testing of Sexually Methods. Kits were mailed out to patients between June 2020 and May 2021. Transmitted Infections in Outpatient Clinics Providers first confirmed patient comfort with self-swab collection during telehealth 1 2 3 Katherine Sittig, MD MPH ; Victoria C. Cunningham, MS ; Rossana Rosa, MD ; appointments. Kits included: an instruction sheet with visual diagrams for collection, 1 1 2 Lisa A. Veach, MD ; UnityPoint Health, Des Moines, Iowa; University of Iowa swabs with appropriate labels; and a pre-paid envelope for patients to mail swabs back Carver College of Medicine, West Des Moines, Iowa; UnityPoint Health - Des to our facility for laboratory testing. Prospective data collection included the date kits Moines, Des Moines, Iowa were mailed out to patients, the date of kit receipt at our facility and the test result. Charts were retrospectively reviewed to determine treatment completion. Session: P-75. Sexually Transmitted Infections Results. 54 self-swab kits were mailed to patients. 53 of the patients were male Background. Screening and diagnosis of Sexually Transmitted Infections (STIs) and the average age was 41.3 years old. 38 (70.3%) swabs were returned. The median requires use of nucleic acid amplifications tests (NAATs) on optimal anatomical spec - time for return of swabs was 21 days (Range 2-289). Of those returned, 5 (13.1%) were imens. Vaginal or cervical swabs are preferred in women and first-catch urine in men. positive and all 5 patients were treated for their infection.  Furthermore, extra-genital testing is recommended for men who have sex with men Conclusion. Mail-out STI testing was effective in identifying STIs for a telehealth (MSM) and for men who have sex with women (MSW) based on exposure history. PrEP program and for maintaining standard of care practice during the COVID-19 Increasingly, STI care is being provided in non-STI specialized settings such as Urgent pandemic. This model may increase rates of testing compliance for care provided via Care (UC) and Primary Care clinics (PC). Therefore, we aimed to characterize the telehealth and decrease rates of STI transmission and complications. Better commu- types of anatomical specimens being utilized for the diagnosis of STIs in non-STI spe- nication around returning kits in a timely-manner and understanding reasons for cialized clinics. non-return warrant further investigation. Methods. We conducted a retrospective analysis of all Neisseria gonorrhea (GC) Disclosures. Monica K. Sikka, MD, FG2 (Scientific Research Study Investigator) and Chlamydia trachomatis (CT) tests obtained at 46 adult outpatient clinics (PC, Christopher D.  Pfeiffer, MD, MHS , C.  difficile Vaccine Trial (Scientific Research UC and Obstetrics & Gynecology [OB/Gyn]) part of an integrated health system in Study Investigator) Des Moines, Iowa, between January 1, 2019 and December 31, 2019. In this database, no information was available regarding patient history of sexual exposure site(s). 1352. Changing Quality Indicators by Monitoring Veterans Using the Sexually Descriptive statistics, including counts, percentages, and differences in proportions TRansmitted Infection Key Evaluation (STRIKE) Dashboard were estimated and stratified by outpatient clinic type. 1 2 Minh Q. Ho, DO ; Linda Chia, PharmD, BCPS ; Matthew Cole, PharmD, BCPS, Results. We identified a total of 18,503 encounters involving 2,802 men and 3 4 4 1 n/a ; Tho  Nguyen, PharmD ; Karen Slazinski, PharmD ; Orlando VA Healthcare 15,701 women. Rates of extragenital testing were overall low, but higher in male patients 2 3 System, 14014 Deep Forest Court, Florida; VA, Bellevue, Washington; VA Capital (14.6%) than in female patients (0.20%). Among male patients, extra-genital testing was Health Care Network (VISN 5), Veterans Health Administration, Huntsville, obtained in 21.1% of patients seen in PCs compared to 5.2% in UCs (p< 0.0001) (Table Alabama; Orlando VA HCS, Orlando, Florida 1). Notably, 177 (50.9%) of the extra-genital samples collected at PCs were obtained at a clinic specializing in the care of MSM. Among female patients, the proportion of urine- Session: P-75. Sexually Transmitted Infections based tests was highest in PC (32%), while non-urine genitourinary samples were more Background. During the COVID-19 pandemic, there have been multiple reports frequently obtained at Ob-Gyn clinics (92.7%) (p< 0.0001) (Table 2). concerning patients falling out of healthcare. The National VA HIV and Hepatitis and Related Conditions (HHRC) has created the Sexually TRansmitted Infection Key Evaluation (STRIKE) Dashboard to help clinicians identify Veterans who need to com- plete co-testing for sexually transmitted infections (STIs) or human immunodeficiency virus (HIV) and allows providers to document if the Veteran was oer ff ed pre-exposure prophylaxis (PrEP). STRIKE Interface Screen Conclusion. Extragenital site testing for GC and CT remains an uncommon prac- tice across all clinic setting types, and high proportions of female patients evaluated at PC and UC clinics were tested using urine specimens. Our results indicate a need for effective education and implementation processes for optimal testing modalities in primary care clinics.  Methods. A national VA Veteran dataset was generated from data within the Disclosures. All Authors: No reported disclosures Corporate Data Warehouse (CDW) that included all active PLWH. Positive HIV status is evaluated based on positive antibody test and positive confirmatory result or positive viral load lab result. Negative HIV status is evaluated based on a negative antibody test 1351. Use of Mail-Out Sexually Transmitted Infection Test Kits in a Telehealth in the past year. Of the 140 sites, 39 participated but only 9 were active throughout the Pre-exposure Prophylaxis Clinic period of October 1, 2020 to March 31, 2021. Active and nonactive participating sites 1 2 2 Monica K. Sikka, MD ; Long Do, Pharm D ; Hanifa Ha, BA ; Dana Smothers, had metrics assessed across the study period at 3 time points: October 1, 2020, January 2 3 4 RN, MS, CNL ; Christopher Evans, MD ; Christopher D. Pfeiffer, MD, MHS ; 1, 2021 and April 1, 2021. Sites with at least 48 visits to report across the 6-month QI 1 2 Oregon Health & Science University, Portland, Oregon; Portland VA Medical period were considered active. Center, Portland, Oregon; Portland VA Medical Center/Oregon Health & Patient level data for review Science University, Portland, Oregon; VA Portland Health Care System, Portland, Oregon HIV, Hepatitis Specialty Telehealth Access Resource (H-START) Collaborative Session: P-75. Sexually Transmitted Infections Background. Standard of care for patients receiving pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) includes HIV screening and test - ing for sexually transmitted infections (STIs) at all sites of potential exposure every three months. We implemented a provider and pharmacist telehealth based PrEP pro- gram as part of the HIV, Hepatitis Specialty Telehealth Access Resource (H-START) Collaborative. Due to the COVID-19 pandemic and care via telehealth, we had limited ability to collect pharyngeal or rectal swabs in clinic. We created mail-out kits includ- ing swabs and instructions for self-collection to test for rectal and pharyngeal Neisseria gonorrhea and Chlamydia trachomatis. S762 • OFID 2021:8 (Suppl 1) • Abstracts http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Open Forum Infectious Diseases Oxford University Press

1350. Characterization of the Type of Specimen Used for Testing of Sexually Transmitted Infections in Outpatient Clinics

Download PDF
1 page

Loading next page...
 
/lp/oxford-university-press/1350-characterization-of-the-type-of-specimen-used-for-testing-of-gqdIvBMrpb

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
eISSN
2328-8957
DOI
10.1093/ofid/ofab466.1542
Publisher site
See Article on Publisher Site

Abstract

1350. Characterization of the Type of Specimen Used for Testing of Sexually Methods. Kits were mailed out to patients between June 2020 and May 2021. Transmitted Infections in Outpatient Clinics Providers first confirmed patient comfort with self-swab collection during telehealth 1 2 3 Katherine Sittig, MD MPH ; Victoria C. Cunningham, MS ; Rossana Rosa, MD ; appointments. Kits included: an instruction sheet with visual diagrams for collection, 1 1 2 Lisa A. Veach, MD ; UnityPoint Health, Des Moines, Iowa; University of Iowa swabs with appropriate labels; and a pre-paid envelope for patients to mail swabs back Carver College of Medicine, West Des Moines, Iowa; UnityPoint Health - Des to our facility for laboratory testing. Prospective data collection included the date kits Moines, Des Moines, Iowa were mailed out to patients, the date of kit receipt at our facility and the test result. Charts were retrospectively reviewed to determine treatment completion. Session: P-75. Sexually Transmitted Infections Results. 54 self-swab kits were mailed to patients. 53 of the patients were male Background. Screening and diagnosis of Sexually Transmitted Infections (STIs) and the average age was 41.3 years old. 38 (70.3%) swabs were returned. The median requires use of nucleic acid amplifications tests (NAATs) on optimal anatomical spec - time for return of swabs was 21 days (Range 2-289). Of those returned, 5 (13.1%) were imens. Vaginal or cervical swabs are preferred in women and first-catch urine in men. positive and all 5 patients were treated for their infection.  Furthermore, extra-genital testing is recommended for men who have sex with men Conclusion. Mail-out STI testing was effective in identifying STIs for a telehealth (MSM) and for men who have sex with women (MSW) based on exposure history. PrEP program and for maintaining standard of care practice during the COVID-19 Increasingly, STI care is being provided in non-STI specialized settings such as Urgent pandemic. This model may increase rates of testing compliance for care provided via Care (UC) and Primary Care clinics (PC). Therefore, we aimed to characterize the telehealth and decrease rates of STI transmission and complications. Better commu- types of anatomical specimens being utilized for the diagnosis of STIs in non-STI spe- nication around returning kits in a timely-manner and understanding reasons for cialized clinics. non-return warrant further investigation. Methods. We conducted a retrospective analysis of all Neisseria gonorrhea (GC) Disclosures. Monica K. Sikka, MD, FG2 (Scientific Research Study Investigator) and Chlamydia trachomatis (CT) tests obtained at 46 adult outpatient clinics (PC, Christopher D.  Pfeiffer, MD, MHS , C.  difficile Vaccine Trial (Scientific Research UC and Obstetrics & Gynecology [OB/Gyn]) part of an integrated health system in Study Investigator) Des Moines, Iowa, between January 1, 2019 and December 31, 2019. In this database, no information was available regarding patient history of sexual exposure site(s). 1352. Changing Quality Indicators by Monitoring Veterans Using the Sexually Descriptive statistics, including counts, percentages, and differences in proportions TRansmitted Infection Key Evaluation (STRIKE) Dashboard were estimated and stratified by outpatient clinic type. 1 2 Minh Q. Ho, DO ; Linda Chia, PharmD, BCPS ; Matthew Cole, PharmD, BCPS, Results. We identified a total of 18,503 encounters involving 2,802 men and 3 4 4 1 n/a ; Tho  Nguyen, PharmD ; Karen Slazinski, PharmD ; Orlando VA Healthcare 15,701 women. Rates of extragenital testing were overall low, but higher in male patients 2 3 System, 14014 Deep Forest Court, Florida; VA, Bellevue, Washington; VA Capital (14.6%) than in female patients (0.20%). Among male patients, extra-genital testing was Health Care Network (VISN 5), Veterans Health Administration, Huntsville, obtained in 21.1% of patients seen in PCs compared to 5.2% in UCs (p< 0.0001) (Table Alabama; Orlando VA HCS, Orlando, Florida 1). Notably, 177 (50.9%) of the extra-genital samples collected at PCs were obtained at a clinic specializing in the care of MSM. Among female patients, the proportion of urine- Session: P-75. Sexually Transmitted Infections based tests was highest in PC (32%), while non-urine genitourinary samples were more Background. During the COVID-19 pandemic, there have been multiple reports frequently obtained at Ob-Gyn clinics (92.7%) (p< 0.0001) (Table 2). concerning patients falling out of healthcare. The National VA HIV and Hepatitis and Related Conditions (HHRC) has created the Sexually TRansmitted Infection Key Evaluation (STRIKE) Dashboard to help clinicians identify Veterans who need to com- plete co-testing for sexually transmitted infections (STIs) or human immunodeficiency virus (HIV) and allows providers to document if the Veteran was oer ff ed pre-exposure prophylaxis (PrEP). STRIKE Interface Screen Conclusion. Extragenital site testing for GC and CT remains an uncommon prac- tice across all clinic setting types, and high proportions of female patients evaluated at PC and UC clinics were tested using urine specimens. Our results indicate a need for effective education and implementation processes for optimal testing modalities in primary care clinics.  Methods. A national VA Veteran dataset was generated from data within the Disclosures. All Authors: No reported disclosures Corporate Data Warehouse (CDW) that included all active PLWH. Positive HIV status is evaluated based on positive antibody test and positive confirmatory result or positive viral load lab result. Negative HIV status is evaluated based on a negative antibody test 1351. Use of Mail-Out Sexually Transmitted Infection Test Kits in a Telehealth in the past year. Of the 140 sites, 39 participated but only 9 were active throughout the Pre-exposure Prophylaxis Clinic period of October 1, 2020 to March 31, 2021. Active and nonactive participating sites 1 2 2 Monica K. Sikka, MD ; Long Do, Pharm D ; Hanifa Ha, BA ; Dana Smothers, had metrics assessed across the study period at 3 time points: October 1, 2020, January 2 3 4 RN, MS, CNL ; Christopher Evans, MD ; Christopher D. Pfeiffer, MD, MHS ; 1, 2021 and April 1, 2021. Sites with at least 48 visits to report across the 6-month QI 1 2 Oregon Health & Science University, Portland, Oregon; Portland VA Medical period were considered active. Center, Portland, Oregon; Portland VA Medical Center/Oregon Health & Patient level data for review Science University, Portland, Oregon; VA Portland Health Care System, Portland, Oregon HIV, Hepatitis Specialty Telehealth Access Resource (H-START) Collaborative Session: P-75. Sexually Transmitted Infections Background. Standard of care for patients receiving pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) includes HIV screening and test - ing for sexually transmitted infections (STIs) at all sites of potential exposure every three months. We implemented a provider and pharmacist telehealth based PrEP pro- gram as part of the HIV, Hepatitis Specialty Telehealth Access Resource (H-START) Collaborative. Due to the COVID-19 pandemic and care via telehealth, we had limited ability to collect pharyngeal or rectal swabs in clinic. We created mail-out kits includ- ing swabs and instructions for self-collection to test for rectal and pharyngeal Neisseria gonorrhea and Chlamydia trachomatis. S762 • OFID 2021:8 (Suppl 1) • Abstracts

Journal

Open Forum Infectious Diseases – Oxford University Press

Published: Dec 4, 2021

There are no references for this article.